Jon Stark of House Biotech - a dream of spring
5.4K posts
Jon Stark of House Biotech - a dream of spring
@Jonny_fun_guy
Biotech is dark and full of errors. just because some random on x said something doesn't mean it's accurate, think for yourself..
🚨 Noelia’s lawyer drops a bombshell… “The hospital pressured for euthanasia because her organs were already committed.”
$wve i (virtually) participated in the study just to show you what a 3% smaller waist looks like in real life. I am wearing here the same belt btw.
Worthwhile to note that we are at a valuation stage in biotech markets where not every good piece of news results in a big run anymore as shown by $DNLI (up 5% today but down since the approval PR) and $MAZE (down 32% on decent data). High expectations seem baked into many names now. Have to be much more selective and much less opportunity in the binary swing-trading now.
Important study tackling a highly relevant question in #EGFRm #NSCLC. One observation: the PFS and OS curves look visually identical, even though the reported medians differ—perhaps suggesting an inadvertent duplication of the PFS KM figure. But, if these represent PFS (based on medians/CIs), the shape of the curve appears somewhat atypical for a randomized trial with scheduled assessments. @ACortelliniMD @DrSanjayPopat @APassaroMD @DiFedericoMD @thenasheffect @myESMO @PTarantinoMD @DrJNaidoo @MarceloCorassa
houndcl was the main one on X who spotlighted the mismatches between the clinicaltrials.gov registration, the published protocol, and the reported findings in that Nature Medicine NSCLC time-of-day immunochemotherapy trial. His detailed critiques helped bring it to the medical community's attention here, leading to the journal's editorial note and ongoing investigation.
I’m honoured to be joining 𝕏 to lead design. I believe this is the most important platform in the world, and I can’t think of a more exciting place to help shape the future. I’m looking forward to working closely with @elonmusk, @nikitabier, and the rest of the team. I’m grateful for the opportunity, humbled to be part of it, and can't wait to get started!
NYC is now putting $2M into "revitalizing" 14th St. since they cut off most of the car traffic and businesses are suffering. You can't make this stuff up.
$IVVD Schimmer importantly, one of the KOLs noted that he's counted ~80 long-COVID patients treated with IVVD's 1st generation COVID antibody and estimates ~65% have had a dramatic response to therapy. IVVD is starting a P2 pbo-controlled study of its next-gen COVID antibody for long COVID - if successful, this could easily be a >$5B/yr unmet need. $IVVD remains a top pick for us - still off many investor radar screens, but we don't think for long.
Is Covid 19 the biggest scam in human history?
Important study tackling a highly relevant question in #EGFRm #NSCLC. One observation: the PFS and OS curves look visually identical, even though the reported medians differ—perhaps suggesting an inadvertent duplication of the PFS KM figure. But, if these represent PFS (based on medians/CIs), the shape of the curve appears somewhat atypical for a randomized trial with scheduled assessments. @ACortelliniMD @DrSanjayPopat @APassaroMD @DiFedericoMD @thenasheffect @myESMO @PTarantinoMD @DrJNaidoo @MarceloCorassa
